5.1 C
Delhi
Friday, January 16, 2026

Tag: Mike Doustdar

Novo Nordisk Cuts Wegovy Price, Plans Oral Weight-Loss Pill Launch

Novo Nordisk reduces Wegovy price to $349 monthly and prepares oral version to compete with Eli Lilly in the US weight-loss drug market.

Novo Nordisk Cuts Forecasts Again Amid Weight-Loss Drug Competition

Ozempic maker Novo Nordisk slashes financial guidance for the fourth time as competition from Eli Lilly and copycat drugs intensifies in the weight-loss market.